Deerfield Management Reveals Position in Newly Public Company Trivascular Technologies Inc (TRIV)

As a new filing with the Securities and Exchange Commission showed, Deerfield Management, a healthcare focused investment firm, managed by James E. Flynn, disclosed a new stake in Trivascular Technologies Inc (NASDAQ:TRIV), a company that began trading on April 16. The stake held by Deerfield amasses close to 632,700 shares, valued at almost $7.6 million.

Trivascular

Trivascular Technologies Inc (NASDAQ:TRIV) is specialized in production and sale of medical devices and technology for invasive treatment of abdominal aortic aneurysms. The company is currently conducting its IPO, during which it plans to sell a total of 6.5 million shares at a price of $12.00 apiece. The IPO price has been set below the price disclosed in one of the amendments to the S-1 form with the SEC, in which the company indicated a price of $15.00 per share.

Among the largest shareholders of the company, is New Enterprise Associates, which together with affiliates holds around 17.7%, followed by Delphi Ventures, which owns 14.2% together with its affiliates, among other investors which hold less significant positions.

Last week, Deerfield Management reported raising its exposure to Insmed Incorporated (NASDAQ:INSM), in which it now holds 3.04 million shares, equal to 7.75% of the outstanding stock. In fact, Mr. Flynn has been bullish on several companies since the beginning of the year, and reported increases in several of its holdings. At the same time the fund initiated positions in several healthcare companies, some of which also right after their IPO. One of them is Cara Therapeutics Inc. (NASDAQ:CARA), in which Deerfield disclosed ownership of 350,000 shares a couple of days after the company went public.

Disclosure: none

Recommended Reading:

James Flynn, Deerfield Management Boost Stake in Streamline Health Solutions Inc. (STRM)

James Flynn, Deerfield Management Step Up Interest In Alphatec Holdings Inc (ATEC)

Deerfield Management Boosts Its Stake in OvaScience Inc (OVAS)

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!